A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/16 (2006.01) A61K 38/11 (2006.01)
Patent
CA 2374681
The present invention provides a method of blocking xenograft rejection in a patient in need of such treatment by administering to said patient a virally- encoded complement control protein, referred to as the inflammation modulatory protein (<i>IMP</i>). The present invention further provides pharmaceutical compositions for the prevention or treatment of xenograft rejection comprising the IMP protein, alone or in combination with other immunosuppressive agents.
L'invention concerne une technique permettant de bloquer le rejet d'une xénogreffe chez un patient nécessitant un tel traitement. Cette technique consiste à administrer à ce patient une protéine régulatrice d'un complément viralement codée, dénommée protéine modulatrice d'inflammation (IMP). L'invention concerne également des compositions pharmaceutiques comprenant la protéine modulatrice d'inflammation, seule ou en combinaison avec d'autres agents immunosuppresseurs, et utilisées pour prévenir ou traiter le rejet de xénogreffe,.
Al-Mohanna Futwan
Kotwal Girish J.
Parhar Ranjit
King Faisal Specialist Hospital And Research Centre
Sim & Mcburney
University Of Louisville Research Foundation Inc.
LandOfFree
Novel therapeutic use of viral inflammation modulatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel therapeutic use of viral inflammation modulatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel therapeutic use of viral inflammation modulatory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1838559